Dementia Flashcards

1
Q

What is dementia? Who does it tend to affect? What are the types and how common are they?

A

It is an acquired, chronic and progressive cognitive impairment which is sufficient to impair ADLs

  • > <65yo = early onset dementia
  • > 5-10% population are over 65y, 20% are over 80yo

Types:
Alzheimers (70%)&raquo_space;> Vascular Dementia&raquo_space;> Dementia with Lewy-bodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How may a patient with dementia present? What are some BPSD?

A

Sx:
1st - forgetfulness, either stepwise or progressive

2nd - disorientation (time -> place -> person) -> management problems

  • Wandering
  • Delusions + Hallucinations
  • Calling out
  • Sleep disturbance
  • Inappropriate behaviour/aggression!

BPSD = behavioural and psychological symptoms of dementia

  • Mood changes
  • Abnormal behaviour
  • Hallucinations/delusions
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What Ix would you do for a patient with suspected dementia?

A

Ix:

  • > Cognitive assessment
  • Screening via AMTS (<7 suggests cognitive impairment), GPCOG
  • Detailed via Addenbrooke’s (ACE-R - 100qs, MMSE - less used now but 30q - where 18-23 is mild cognitive impairment and <18 is severe, MoCA)
  • > Dementia/delirium screen
  • TFTs (hypothyroid can cause cognitive decline)
  • LFTs (Korsakoff’s)
  • U&Es and dipstick (infection, diabetes)
  • HbA1c
  • B12 and folate

+ Specific tests for each type of dementia
[Further tests]
- Alzheimers - FDG-PET, MRI (grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy)
- Vascular - ECG (AF with emboli), MRI/CT
- Lewy-body - DaTScan; a tracer 123-I-FP-CIP used in single photon emission CT
- Frontotemporal - FDG-PET, perfusion SPECT, MRI (frontal lobe shrinkage)

AFTER GP: -> Memory Assessment Clinic Referral

  • > Take collateral Hx and check bloods
  • > Risk assess the patient
  • > Cognitive assessment (MMSE)
  • > Brain scan for organic pathology
  • > Differentiate delirium vs dementia (confusion assessment method and observational scale of level of arousal - CAM + OSLA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Alzheimers and what are the 3 theories regarding its pathophysiology?

A

Alzheimers is the most common form of dementia, with a steady progression (affects hippocampus first in pathophysiology)

Pathophysiology:
- Amyloid = Normally APP is cleaved by alpha-secretase to form sAPP-alpha and C83. C83 is degraded by gamma-secretase and removed. In AD, APP is cleaved by beta-secretase to form sAPP-beta and C99. C99 is digested by gamma-secretase to form beta-amyloid protein which forms toxic aggregates

  • Tau = Tau is a soluble protein in axons used in assembly and neurone stability. Hyper-phosphorylation of Tau in AD makes it insoluble causing it to self-aggregate and form neurofibrillary tangles which cause microtubule instability and neurotoxic damage to the neurones.
  • Inflammation = there are increased inflammatory mediators and cytotoxic proteins in AD, and therefore increased phagocytosis by the microglial cells (specialist CNS macrophages) which therefore reduces the levels of neuroprotective proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some risk factors for AD? [Think biopsychosocial]

A

RFs:

Bio:

  • AGE = main RF, 1% at 60, and risk doubles every 5 years
  • Genetics (8% of risk, 92% sporadic) - genes including APEN, APP, ApoE, Presenilin 1 gene (X14), Presenillin 2 gene (X1), APP (X21 - Coexistent Downs increases risk)
  • Head injury
  • Vascular RFs e.g. HTN

Psychosocial:

  • Low IQ
  • Poor educational level
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How may a patient present with AD, and why do these symptoms occur?

A

Sx:

  • Early = failing memory, wandering, irritability
  • Middle = The 4A’s become apparent* - Amnesia, Aphasia, Agnosia and Apraxia
  • Late = fully dependent, incontinence, primitive reflexes, extrapyramidal symptoms
  • Other = BPSD - mood changes, abnormal behaviour and hallucinations/delusions
  • Other = psychiatric symptoms such as depression, delusions, GAD, behavioural disturbances (note: patients with depression may do badly on MSE due to ‘depressive pseudodementia’)

** 4 As
Amnesia - Recent memories lost first, disorientation occurs early
Aphasia - finding correct words (Broca’s), speech muddled/disjointed
Agnosia - usually visual e.g. with faces (propagnosia)
Apraxia - usually with dressing, skilled tasks despite normal motor function

Causes of Sx due to atrophy, plaque and NF tangle formation and cholinergic loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What investigations would you do in a patient with suspected AD?

A

Ix - same as dementia:

  • > Cognitive assessment
  • Screening via AMTS (<7 suggests cognitive impairment), GPCOG
  • Detailed via Addenbrooke’s (ACE-R - 100qs, MMSE - less used now but 30q - where 18-23 is mild cognitive impairment and <18 is severe, MoCA)
  • > Dementia/delirium screen
  • TFTs (hypothyroid can cause cognitive decline)
  • LFTs (Korsakoff’s)
  • U&Es and dipstick (infection, diabetes)
  • HbA1c
  • B12 and folate

+ Specific tests for each type of dementia
[Further tests]
- Alzheimers - FDG-PET, MRI (grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy)
- ECG pre-medication as QT prolongation, non-pacemaker treated heart block and HR<50 are contraindications!
- Also check co-morbid conditions for contraindications!!

DDx:

  • Vascular - ECG (AF with emboli), MRI/CT
  • Lewy-body - DaTScan; a tracer 123-I-FP-CIP used in single photon emission CT
  • Frontotemporal - FDG-PET, perfusion SPECT, MRI (frontal lobe shrinkage)

AFTER GP: -> Memory Assessment Clinic Referral

  • > Take collateral Hx and check bloods
  • > Risk assess the patient
  • > Cognitive assessment (MMSE)
  • > Brain scan for organic pathology
  • > Differentiate delirium vs dementia (confusion assessment method and observational scale of level of arousal - CAM + OSLA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are some good and bad prognostic factors for AD?

A

Good - female

Bad - male, depression, behavioural problems, severe focal cognitive deficit

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How would you manage AD? What checks are important in f/u?

A

Biological: ‘start low, go slow’ aiming to raise ACh

  • Anticholineserases (mild-moderate AD) such as Donepezil, Galantamine, Rivastigmine
  • 2nd line (moderate or 1st line for severe AD) = Memantine, a partial NMDA receptor agonist

Psychological:

  • 1st line = Structural group cognitive stimulation sessions (mild-moderate AD)
  • Exclude depression or GAD
  • Other = group reminiscence therapy, validation/reassurance therapy, multi sensory therapy

Social:

  • Explain Dx and signpost support
  • Optimise health in other areas such as hearing, visual aids
  • Identify future wishes - advanced directives, lasting power of attorney
  • F/u every 6m with patient and care manager (w care plan)
  • Home + needs assessment: general social support such as dose boxes, changing gas to electricity, assistive house measures, identify and support any carers involved, meal supports and day centres
  • CARER’s assessment!
  • Legally required to inform DVLA and insurers for any form of dementia (review license yearly)

Other:

  • Due to AChE you need to check ECG and SE (GI such as N+V, anorexia, dizziness, headaches, fatigue)
  • Absolute CI to AChE are anticholinergics, B-blockers, NSAIDs, muscle relaxants, other relative CI are asthma/COPD, GI disease, bradycardia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Vascular dementia? What are some RFs?

A

Dementia which is caused by infarcts due to thromboembolism or narrowing of arteries due to HTN

RFs are same as CVD:

  • HTN
  • Male
  • Obesity
  • Smoking
  • Sedentary/reduced exercise
  • DM
  • AF, Hx of stroke or TIA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How may a patient with vascular dementia present?

A

Sx:

  • SUDDEN onset (may follow CVA, with STEPWISE deterioration
  • 1st = emotional and minor personality changes (labile emotion so from tearful -> elation)
  • 2nd = cognitive deficit
  • Focal neurological signs (reflect site of infarct i.e. upward plantars, left arm, some cognition reserved)
  • Co-morbid depression
  • Relatively preserved personality (not like AD where “mum is not herself anymore” but just “different and not using arm as much”)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How would you investigate VD?

A

Ix (same as dementia):

  • > Cognitive assessment
  • Screening via AMTS (<7 suggests cognitive impairment), GPCOG
  • Detailed via Addenbrooke’s (ACE-R - 100qs, MMSE - less used now but 30q - where 18-23 is mild cognitive impairment and <18 is severe, MoCA)
  • > Dementia/delirium screen
  • TFTs (hypothyroid can cause cognitive decline)
  • LFTs (Korsakoff’s)
  • U&Es and dipstick (infection, diabetes)
  • HbA1c
  • B12 and folate

+ Specific tests for each type of dementia
[Further tests]
- Alzheimers - FDG-PET, MRI (grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy)
- Vascular - ECG (AF with emboli), MRI/CT
- Lewy-body - DaTScan; a tracer 123-I-FP-CIP used in single photon emission CT
- Frontotemporal - FDG-PET, perfusion SPECT, MRI (frontal lobe shrinkage)

AFTER GP: -> Memory Assessment Clinic Referral

  • > Take collateral Hx and check bloods
  • > Risk assess the patient
  • > Cognitive assessment (MMSE)
  • > Brain scan for organic pathology
  • > Differentiate delirium vs dementia (confusion assessment method and observational scale of level of arousal - CAM + OSLA)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How would you Mx VD?

A

Mx:
Biological:
- Daily aspirin (if indicated due to CVA/AF risk)
- Reduce risk factors (increased exercise, stop smoking, treat HTN and AF, control DM)

Psychological:

  • 1st line = Structural group cognitive stimulation sessions
  • Exclude depression or GAD
  • Other = group reminiscence therapy, validation/reassurance therapy, multi sensory therapy

Social:

  • Explain Dx and signpost support
  • Optimise health in other areas such as hearing, visual aids
  • Identify future wishes - advanced directives, lasting power of attorney
  • F/u every 6m with patient and care manager (w care plan)
  • General social support such as dose boxes, changing gas to electricity, assistive house measures, identify and support any carers involved, meal supports and day centres
  • Legally required to inform DVA and insurers for any form of dementia (review license yearly)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is Dementia with LB? How is this different to Parkinson’s? What are some RFs?

A

Lewy bodies are alpha-synuclein with ubiquitin

Spectrum of diseases including Lewy-bodies from DLB —-> Parkinsons disease

  • In Parkinson’s, LB are found in the brainstem
  • In DLB, LB are found in the brainstem, cingulate gyrus and neocortex

RFs = Age, unknown

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How may a patient with DLB present?

A

Sx (must be at least 2/+ out of 3, general gradual decline):

  • Fluctuating confusion with marked variations in alertness levels (may resemble delirium) i.e. has some LUCID intervals unlike other dementias
  • Vivid visual hallucinations (Lilliputian hallucinations) - of animals or humans
  • Parkinsonism - shuffling gait, hypomimia, bradykinesia, rigidity [note anosmia is an early sign of PD]
  • Frequent falls
  • Co-morbid depression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What Ix would you do in suspected LBD?

A

Ix (same as dementia):

  • > Cognitive assessment
  • Screening via AMTS (<7 suggests cognitive impairment), GPCOG
  • Detailed via Addenbrooke’s (ACE-R - 100qs, MMSE - less used now but 30q - where 18-23 is mild cognitive impairment and <18 is severe, MoCA)
  • > Dementia/delirium screen
  • TFTs (hypothyroid can cause cognitive decline)
  • LFTs (Korsakoff’s)
  • U&Es and dipstick (infection, diabetes)
  • HbA1c
  • B12 and folate

+ Specific tests for each type of dementia
[Further tests]
- Alzheimers - FDG-PET, MRI (grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy)
- Vascular - ECG (AF with emboli), MRI/CT
- Lewy-body - DaTScan; a tracer for 123-I-FP-CIP used in single photon emission CT
- Frontotemporal - FDG-PET, perfusion SPECT, MRI (frontal lobe shrinkage)

AFTER GP: -> Memory Assessment Clinic Referral

  • > Take collateral Hx and check bloods
  • > Risk assess the patient
  • > Cognitive assessment (MMSE)
  • > Brain scan for organic pathology
  • > Differentiate delirium vs dementia (confusion assessment method and observational scale of level of arousal - CAM + OSLA)
17
Q

How would you manage DLB?

A

Biological:

  • 1st line = AChE such as Donepezil or Rivastigmine
  • DO NOT offer antipsychotics as increased chance of cerebrovascular disease

Psychological:

  • 1st line = Structural group cognitive stimulation sessions
  • Exclude depression or GAD
  • Other = group reminiscence therapy, validation/reassurance therapy, multi sensory therapy

Social:

  • Explain Dx and signpost support
  • Allocate care coordinator !
  • Optimise health in other areas such as hearing, visual aids
  • Identify future wishes - advanced directives, lasting power of attorney
  • F/u every 6m with patient and care coordinator
  • General social support such as dose boxes, changing gas to electricity, assistive house measures, identify and support any carers involved, meal supports and day centres
  • Legally required to inform DVLA and insurers for any form of dementia (review license yearly)
18
Q

What is frontotemporal dementia and who does it affect?

What is the pathology?

A

Atrophy of the fronto-temporal regions

  • Early onset - occurs usually between the ages of 40 to 60/65 years
  • 60% sporadic, 40% autosomal inheritance

2 pathologies with no correlation to clinical presentation:

  • Tau +ve = Pick’s, CBD, PSP [Pick’s bodies = hyperphosphorylated Tau]
  • Tau -ve = FTLD-U [Frontotemporal lobar dementia with ubiquinated inclusions)
19
Q

How may FTLD present (3 clinical presentations)?

A

Sx:
[1] Frontotemporal dementia -> frontal lobe syndrome = disinhibition, social/personality changes
[2] Semantic dementia -> progressive loss of understanding of verbal and visual meaning
[3] Progressive non-fluent aphasia -> 1st naming difficulties occurs, then 2nd is mutism

Memory tends to be affected much later, unlike in AD where it can be the first thing affected

20
Q

What Ix would you do for FTLD?

A

Ix (same as dementia):

  • > Cognitive assessment
  • Screening via AMTS (<7 suggests cognitive impairment), GPCOG
  • Detailed via Addenbrooke’s (ACE-R - 100qs, MMSE - less used now but 30q - where 18-23 is mild cognitive impairment and <18 is severe, MoCA)
  • > Dementia/delirium screen
  • TFTs (hypothyroid can cause cognitive decline)
  • LFTs (Korsakoff’s)
  • U&Es and dipstick (infection, diabetes)
  • HbA1c
  • B12 and folate

+ Specific tests for each type of dementia
[Further tests]
- Alzheimers - FDG-PET, MRI (grey matter atrophy, wide ventricles and sulci, temporal lobe atrophy)
- Vascular - ECG (AF with emboli), MRI/CT
- Lewy-body - DaTScan; a tracer for 123-I-FP-CIP used in single photon emission CT
- Frontotemporal - FDG-PET, perfusion SPECT, MRI (frontal lobe shrinkage)

AFTER GP: -> Memory Assessment Clinic Referral

  • > Take collateral Hx and check bloods
  • > Risk assess the patient
  • > Cognitive assessment (MMSE)
  • > Brain scan for organic pathology
  • > Differentiate delirium vs dementia (confusion assessment method and observational scale of level of arousal - CAM + OSLA)
21
Q

How would you manage FTLD and what is its prognosis?

A

Biological:
- Antidepressants to treat frontal lobe syndrome

Psychological:

  • 1st line = Structural group cognitive stimulation sessions
  • Exclude depression or GAD
  • Other = group reminiscence therapy, validation/reassurance therapy, multi sensory therapy

Social:

  • Explain Dx and signpost support
  • Optimise health in other areas such as hearing, visual aids
  • Identify future wishes - advanced directives, lasting power of attorney
  • F/u every 6m with patient and care manager (w care plan)
  • General social support such as dose boxes, changing gas to electricity, assistive house measures, identify and support any carers involved, meal supports and day centres
  • Legally required to inform DVLA and insurers for any form of dementia (review license yearly)
  • OT, SALT and physiotherapy

Prognosis -> death in 5-10 years

22
Q

What is Huntington’s disease and who does it affect?

A

Huntington’s disease is an autosomal dominant progressive neurodegenerative disorder. Affects basal ganglia:

  • Onset at 30-50y
  • Trinucleotide repeats [CAG]
  • Exhibits genetic anticipation (onset and severity of disease may be younger and greater in successive generations)
  • HTT (Huntingtin) gene affected
23
Q

How does Huntington’s present?

A

Sx: ‘clumsy and speech difficulties’

  • Movement = clumsiness/stumbling, chorea*, speech/swallowing
  • Cognitive = difficulty in organising tasks, concentrating, impulse control, learning new information
  • Psychiatric = depression, irritability/mood swings, suicide (9% cases), personality change

Lack of insight - don’t care that anything is wrong

*Chorea = involuntary jerking or fidgety movements that tend to ‘flow’ from one area to another (dance-y)

24
Q

How would you Ix Huntington’s?

A

Ix:

  • Full Hx and FHx
  • Genetic analysis (HTT gene)
  • MMSE may be normal
25
Q

What is the definition of delirium (DSM-V)?

A

Delirium is defined as:
A - disturbance in attention and awareness
B - brief and baseline (disturbance develops over a short period of time and represents a change from baseline attention and awareness and FLUCTUATES in severity over the course of the day)
C - additional disturbance in cognition
D - disturbances aren’t better explained by another condition
E - evidence from Hx, O/E or laboratory findings that disturbance is a direct physiological consequence of another medical condition, substance intoxication or withdrawal

26
Q

Who does delirium tend to affect?

A

Epidemiology:

  • > On admission, 10-30% aged 65+
  • > After admission, 30% new onset on acute wards, 80% ICU
  • > 20% in care homes
  • > 50% never recognised
27
Q

What are some causes of delirium? What is important to remember?

A
Some causes
[note: do not be satisfied with just one cause as there may be many]
- Infection (UTI, RTI)
- Medication (anti-ACh, steroids, opiates)
- Encephalitis
- Constipation
- Alcohol withdrawal
- Liver/renal impairment
- Hyponatremia
- Dehydration
- Stroke
- Hypoxia
- Surgery, Pain
- Change in environment
- Urine retention
28
Q

What Ix would you do for suspected delirium?

A

Ix:

  • Confusion assessment method (CAM)
  • > Delirium requires [1], [2] and [3] or [4] where [1 = acute onset of mental status changes/fluctuating course], [2= inattention], [3=disorganised thinking] and [4=altered level of consciousness]
  • Bloods for possible causes e.g. Na+
  • Physical exam - urine retention, pain, stroke
29
Q

What is the management for suspected delirium? What is its prognosis?

A

Mx:

  • Modify RFs if possible
  • Exclude undiagnosed dementia
  • Treat the cause/s
  • Single room, well lit and with friends/family if possible
  • Medication = PO antipsychotics (+ AVOID anti-cholinergics)

Prognosis: 37% die within 6m, 43% have reversible cognitive impairment and only 25% had clinically important recovery in ADLs